• Citer

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials.

par Atalay, G;Biganzoli, Laura ;Renard, Françoise ;Paridaens, R. ;Cufer, T;Coleman, R;Calvert, A H;Gamucci, T;Minisini, A;Therasse, P.;Piccart-Gebhart, Martine ;EORTC Breast Cancer and Early Clinical Studies Groups,
Référence European journal of cancer, 39, 17, page (2439-2449)
Publication Publié, 2003-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials.
Auteur:	Atalay, G; Biganzoli, Laura; Renard, Françoise; Paridaens, R.; Cufer, T; Coleman, R; Calvert, A H; Gamucci, T; Minisini, A; Therasse, P.; Piccart-Gebhart, Martine; EORTC Breast Cancer and Early Clinical Studies Groups,
Informations sur la publication:	European journal of cancer, 39, 17, page (2439-2449)
Statut de publication:	Publié, 2003-11
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Antineoplastic Agents -- therapeutic use
	Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
	Breast Neoplasms -- drug therapy
	Clinical Trials, Phase III as Topic
	Cyclophosphamide -- therapeutic use
	Doxorubicin -- therapeutic use
	Female
	Humans
	Liver Neoplasms -- drug therapy
	Liver Neoplasms -- secondary
	Multicenter Studies as Topic
	Paclitaxel -- therapeutic use
	Prospective Studies
	Randomized Controlled Trials as Topic
	Retrospective Studies
	Treatment Outcome
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	Review
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:pii/S0959804903006014
	info:pmid/14602130